M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity

  title={M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity},
  author={Karthik A Jagadeesh and Aaron M. Wenger and Mark J. Berger and Harendra Guturu and Peter D. Stenson and David N. Cooper and J A Bernstein and Gill Bejerano},
  journal={Nature Genetics},
Variant pathogenicity classifiers such as SIFT, PolyPhen-2, CADD, and MetaLR assist in interpretation of the hundreds of rare, missense variants in the typical patient genome by deprioritizing some variants as likely benign. These widely used methods misclassify 26 to 38% of known pathogenic mutations, which could lead to missed diagnoses if the classifiers are trusted as definitive in a clinical setting. We developed M-CAP, a clinical pathogenicity classifier that outperforms existing methods… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 69 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 58 extracted citations

A non-functional galanin receptor-2 in a multiple sclerosis patient

The Pharmacogenomics Journal • 2018
View 2 Excerpts
Highly Influenced

Exome Pool-Seq in neurodevelopmental disorders

European Journal of Human Genetics • 2017
View 4 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 26 references

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies

C. Dong
Hum . Mol . Genet . • 2015

UniProt: a hub for protein information

The Uniprot Consortium
Nucleic Acids Research • 2015

A general framework for estimating the relative pathogenicity of human genetic variants

M. Kircher
Nat . Genet . • 2014

Similar Papers

Loading similar papers…